Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Response of low-grade oligodendroglial tumors to temozolomide.

Byrne TN. Response of low-grade oligodendroglial tumors to temozolomide. J Neurooncol. 2004 Dec; 70(3):279-80.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.